We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+3.63%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$4.45B
AUM Growth
+$192M
Cap. Flow
+$96.4M
Cap. Flow %
2.17%
Top 10 Hldgs %
37.03%
Holding
3,677
New
275
Increased
1,530
Reduced
993
Closed
158
Avg Time Held Equity + Options
4.4 years
Top 10 Avg Time Held Equity + Options
2.4 years
Top 20 Avg Time Held Equity + Options
3.6 years
Avg Time Held Equity only
4.4 years
Top 10 Avg Time Held Equity only
2.4 years
Top 20 Avg Time Held Equity only
3.6 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.71%
2 Technology 16.97%
3 Healthcare 8.95%
4 Financials 7.08%
5 Communication Services 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AKO.B icon
3476
Embotelladora Andina Series B
AKO.B
$4.38B
$18 ﹤0.01%
1
– –
2024 Q1
3 quarters
OABI icon
3477
OmniAb
OABI
$662M
$14 ﹤0.01%
4
– –
2022 Q4
8 quarters
DCTH icon
3478
Delcath Systems
DCTH
$511M
$12 ﹤0.01%
1
– –
2020 Q2
18 quarters
BLE icon
3479
DELISTED
BlackRock Municipal Income Trust II
BLE
$11 ﹤0.01%
+1
New +$11
2024 Q4
0 quarters
HOS icon
3480
Hornbeck Offshore Services, Inc.
HOS
$2.25B
$9 ﹤0.01%
1
– –
2021 Q2
14 quarters
OCUL icon
3481
Ocular Therapeutix
OCUL
$1.58B
$9 ﹤0.01%
1
– –
2024 Q3
1 quarter
EHAB icon
3482
DELISTED
Enhabit
EHAB
$8 ﹤0.01%
1
– –
2022 Q3
9 quarters
ABVEW
3483
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$8 ﹤0.01%
300
– –
2024 Q3
1 quarter
AVTX icon
3484
Avalo Therapeutics
AVTX
$635M
$7 ﹤0.01%
1
– –
2020 Q1
19 quarters
KALA icon
3485
KALA BIO
KALA
$3.64M
– –
0
– –
2021 Q1
15 quarters
NKLA icon
3486
DELISTED
Nikola Corporation Common Stock
NKLA
$6 ﹤0.01%
5
– –
2020 Q3
17 quarters
XXII
3487
22nd Century Group
XXII
$465K
– –
0
– –
2018 Q2
26 quarters
AVAL icon
3488
Grupo Aval
AVAL
$5.82B
$4 ﹤0.01%
2
– –
2019 Q1
23 quarters
ALZN icon
3489
Alzamend Neuro
ALZN
$6.51M
– –
0
– –
2023 Q4
4 quarters
IMUX icon
3490
Immunic
IMUX
$90.9M
– –
0
– –
2018 Q2
26 quarters
CCO icon
3491
Clear Channel Outdoor Holdings
CCO
$1.23B
$1 ﹤0.01%
1
– –
2023 Q2
6 quarters
GWAV icon
3492
Greenwave Technology Solutions
GWAV
$2.05M
– –
0
– –
2023 Q1
7 quarters
VIRX icon
3493
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1 ﹤0.01%
8
– –
2018 Q4
24 quarters
ACB icon
3494
Aurora Cannabis
ACB
$264M
– –
-8
Closed -$47 –
ALEC icon
3495
Alector
ALEC
$210M
– –
-15
Closed -$70 –
AMN icon
3496
AMN Healthcare
AMN
$1.46B
– –
-16
Closed -$678 –
ANIK icon
3497
Anika Therapeutics
ANIK
$271M
– –
-39
Closed -$963 –
ARTNA icon
3498
Artesian Resources
ARTNA
$347M
– –
-667
Closed -$24.8K –
ASPN icon
3499
Aspen Aerogels
ASPN
$428M
– –
-22
Closed -$609 –
AWF icon
3500
AllianceBernstein Global High Income Fund
AWF
$814M
– –
-225
Closed -$2.55K –

Similar funds

Parallel Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Parallel Advisors held 3,677 positions worth $4.45B, up 4.5% from $4.25B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors's Q4 2024 filing shows 275 new, 1,530 increased, 993 reduced and 158 closed positions. Its largest new stake was PIMCO Ultra Short Government Active ETF: 67,253 shares worth $6.78M. The largest sale was State Street SPDR Bloomberg 3-12 Month T-Bill ETF, an estimated $8.95M.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 48% a quarter earlier, followed by Technology and Healthcare.

  • Parallel Advisors's largest Q4 2024 buy was PIMCO Ultra Short Government Active ETF: 67,253 shares worth $6.78M.
  • Parallel Advisors added most to Crown Castle in Q4 2024, an estimated $18.7M increase.
  • Parallel Advisors's biggest Q4 2024 reduction was State Street SPDR Bloomberg 3-12 Month T-Bill ETF, cutting an estimated $8.95M.
  • Parallel Advisors fully exited iShares iBonds Dec 2024 Term Corporate ETF in Q4 2024, selling an estimated $3.68M.
  • Parallel Advisors's ten largest holdings make up 37% of its $4.45B portfolio in Q4 2024.
  • Parallel Advisors opened 275 new positions and closed 158 in Q4 2024.
  • Parallel Advisors's portfolio value rose 4.5% quarter-over-quarter to $4.45B.

Based on Parallel Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.